HCV - Difficulty In Treating Older Hepatitis C Patients With Combination Therapy

Difficulty In Treating Older Hepatitis C Patients With Combination Therapy
Medical News Today - Jan 07 8:07 AM
A new study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.Save to My Web

AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus
[Press Release] Business Wire via Yahoo! Finance - Jan 13 6:00 AM
PORTLAND, Ore.----Jan. 13, 2006--AVI BioPharma, Inc. , today announced publication of significant research carried out in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases .Save to My Web

MIGENIX to Initiate MX-3253 HCV Viral Kinetics Study in Treatment Naive Patients; CEO Message No. 17 Released
[Press Release] CNW Group via Yahoo! Finance - Jan 23 9:19 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, released the Company's 17th CEO Message today. The CEO Message provides an overview of the MX-3253 and CPI-226 clinical programs for 2006 and the first half of 2007, including the Company's plan to initiate a combination therapy viral kinetics clinical trial of celgosivir in Hepatitis C virus patients.Save to My Web

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19 6:08 PM
Californian biopharm company Peregrine Pharmaceuticals has accelerated its clinical program for Tarvacin, an anti-viral designed to treat chronic hepatitis C, expecting to complete patient dosing in its present study months ahead of schedule.Save to My Web

HGS Signs Amgen, PDL For Partners In Non-Core Assets
BioWorld - Jan 10 6:05 PM
In a flurry of activity this week, Human Genome Sciences Inc. and its recently formed CoGenesys division agreed to a pair of out-licensing deals, and at the same time, the parent firm received a $5 million milestone payment as part of an older agreement.Save to My Web